Skip to main content

Advertisement

Table 1 Demographic, clinical and virological features of the 82 HIV-HCV co-infected patients who fulfilled the inclusion criteria

From: HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study

Variables Results
Age (years)1 48 (±6)
Male, n (%)2 62 (75.6)
HCV Genotype 1, n (%)2 48 (58.5)
Previous HCV therapy, n (%)2 17 (20.7)
Advanced liver fibrosis, n (%)2 19 (23.2)
CD4 cell count at T11 (cells/mm3) 576 (±280)
CD4 cell count at T21 (cells/mm3) 654 (±351)
HCV RNA at T11 (IU/ml) 3924650 (±5320177)
HCV RNA at T21 (IU/ml) 3085128 (±3372347)
Ongoing ART at T22, n (%) 73 (89)
Clean IFU, n (%)2 39 (47.6)
Clean FFU5, n (%)2 57 (69.5)
Discordant HIV RNA suppression at IFU4, n (%) 14 (17.1)
IL 28B CC genotype, n (%)2 20 (31.7)
  1. 1mean and SD; 2absolute number and percentage respect to all included patients.
  2. ART: Anti Retroviral Therapy; Clean IFU: HIV viremia undetectable during initial follow-up (0-24 months from T1), regardless of being on ART; Clean FFU: HIV viremia undetectable during final follow-up (24-36 months from T1), regardless of being on ART.
  3. Data on IL28B genotype were available for the 63 patients (76.8%).